SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.40+5.5%Nov 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (327)3/11/2003 4:12:14 PM
From: JMarcus  Read Replies (1) of 3722
 
EPIX is up about 10% on the highest the stock has seen since Oct. 14th. Ron Garren, of www.biotechinsight.com, plugged the stock for the first time in the article he posted this week at www.biospace.com. Here's the link.

biospace.com

Here's the text of what he said:

<<The results of the second Phase III vascular imaging trial announced Friday by Epix Medical (EPIX) clearly seems to show they have a great MRI vascular imaging agent. The technology basically uses a standard a MRI contrast agent modified so that it binds to albumin, a circulating protein. This keeps the agent (MS-325) inside the vascular tree allowing almost anatomic imaging of vascular problems. It looks as good as the gold standard, which is IV contrast angiography but without the downsides of potential kidney damage, bleeding and allergic reactions. EPIX with a market cap of approximately $127 million looks cheap for a company that may set a new standard of care. Management expects the final two Phase III trials to report this summer and a possible filing in the fall of '03. If and when MRI technology gets up to speed for cardiovascular imaging this could open another huge market. The company is in partnership with Schering AG in the US and gets royalties from the rest of the world. I just bought some for my personal account. >>

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext